{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["E. coli", "Immune Epitope Database", "Lateral Flow Immunoassay", "SARS-CoV2", "nucleocapsid protein", "point-of-care", "stability"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37892206", "DateCompleted": {"Year": "2023", "Month": "10", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "30"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "10", "Day": "14"}], "ELocationID": ["1524", "10.3390/biom13101524"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "13", "Issue": "10", "PubDate": {"Year": "2023", "Month": "Oct", "Day": "14"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Improved Stability and Manufacturability of Nucleocapsid Antigens for SARS-CoV2 Diagnostics through Protein Engineering.", "Abstract": {"AbstractText": ["The COVID-19 pandemic has had a significant impact on human health management. A rapid diagnosis of SARS-CoV2 at the point-of-care (POC) is critical to prevent disease spread. As a POC device for remote settings, a LFIA should not require cold-chain maintenance and should be kept at normal temperatures. Antigen stability can be enhanced by addressing instability issues when dealing with fragile components, such as proteinaceous capture antigens. This study used immunologically guided protein engineering to enhance the capture nucleocapsid (NP) antigen stability of SARS-CoV2. A search of the IEDB database revealed that antibodies detecting epitopes are almost uniformly distributed over NP<sub>1-419</sub>. In contrast, N-terminal stretches of NP<sub>1-419</sub> are theoretically more unstable than C-terminal stretches. We identified NP<sub>250-365</sub> as a NP stretch with a low instability index and B-cell epitopes. Apart from NP<sub>1-419</sub>, two other variants (NP<sub>121-419</sub> and NP<sub>250-365</sub>) were cloned, expressed, and purified. The degradation pattern of the proteins was observed on SDS-PAGE after three days of stability studies at -20 \u00b0C, 4 \u00b0C, and 37 \u00b0C. NP<sub>1-419</sub> was the most degraded while NP<sub>250-365</sub> exhibited the least degradation. Also, NP<sub>1-419</sub>, NP<sub>250-365</sub>, and NP<sub>121-419</sub> reacted with purified antibodies from COVID-19 patient serum. Our results suggest that NP<sub>250-365</sub> may be used as a stable capture antigen in LFIA devices to detect COVID-19."]}, "AuthorList": [{"Identifier": ["0000-0003-4259-1948"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprocess and Bioproduct Development Laboratory, University School of Biotechnology, Guru Gobind Singh Indraprastha University, Dwarka, New Delhi 110078, India."}], "LastName": "Shukla", "ForeName": "Esha", "Initials": "E"}, {"Identifier": ["0000-0002-7653-1217"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprocess and Bioproduct Development Laboratory, University School of Biotechnology, Guru Gobind Singh Indraprastha University, Dwarka, New Delhi 110078, India."}], "LastName": "Choudhury", "ForeName": "Lipsa", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprocess and Bioproduct Development Laboratory, University School of Biotechnology, Guru Gobind Singh Indraprastha University, Dwarka, New Delhi 110078, India."}], "LastName": "Rastogi", "ForeName": "Saurabh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprocess and Bioproduct Development Laboratory, University School of Biotechnology, Guru Gobind Singh Indraprastha University, Dwarka, New Delhi 110078, India."}], "LastName": "Chawla", "ForeName": "Arshmeet", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, Indian Institute of Technology New Delhi, Hauz Khas, New Delhi 110016, India."}], "LastName": "Bhattacharya", "ForeName": "Sanghati", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medsource Ozone Biomedicals Pvt. Ltd., Parmeshwari Colony, Faridabad 121003, India."}], "LastName": "Kaushik", "ForeName": "Umesh", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medsource Ozone Biomedicals Pvt. Ltd., Parmeshwari Colony, Faridabad 121003, India."}], "LastName": "Mittal", "ForeName": "Manan", "Initials": "M"}, {"Identifier": ["0000-0002-5913-4244"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, Indian Institute of Technology New Delhi, Hauz Khas, New Delhi 110016, India."}], "LastName": "Rathore", "ForeName": "Anurag Singh", "Initials": "AS"}, {"Identifier": ["0000-0002-0115-3397"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprocess and Bioproduct Development Laboratory, University School of Biotechnology, Guru Gobind Singh Indraprastha University, Dwarka, New Delhi 110078, India."}], "LastName": "Pandey", "ForeName": "Gaurav", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "RNA, Viral"}, {"RegistryNumber": "0", "NameOfSubstance": "Antigens"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["diagnosis"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "RNA, Viral"}, {"QualifierName": ["genetics"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Antigens"}, {"QualifierName": [], "DescriptorName": "Nucleocapsid"}, {"QualifierName": [], "DescriptorName": "COVID-19 Testing"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Li G., Li W., Fang X., Song X., Teng S., Ren Z., Hu D., Zhou S., Wu G., Li K. Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection. Protein Expr. Purif. 2021;186:105908. doi: 10.1016/j.pep.2021.105908.", "ArticleIdList": ["10.1016/j.pep.2021.105908", "PMC8150265", "34048905"]}, {"Citation": "Zhou Y., Wu Y., Ding L., Huang X., Xiong Y. Point-of-care COVID-19 diagnostics powered by lateral flow assay. Trends Anal. Chem. TRAC. 2021;145:116452. doi: 10.1016/j.trac.2021.116452.", "ArticleIdList": ["10.1016/j.trac.2021.116452", "PMC8487324", "34629572"]}, {"Citation": "Di Nardo F., Chiarello M., Cavalera S., Baggiani C., Anfossi L. Ten Years of Lateral Flow Immunoassay Technique Applications: Trends, Challenges and Future Perspectives. Sensors. 2021;21:5185. doi: 10.3390/s21155185.", "ArticleIdList": ["10.3390/s21155185", "PMC8348896", "34372422"]}, {"Citation": "Mariano G., Farthing R.J., Lale-Farjat S.L.M., Bergeron J.R.C. Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be. Front. Mol. Biosci. 2020;7:344. doi: 10.3389/fmolb.2020.605236.", "ArticleIdList": ["10.3389/fmolb.2020.605236", "PMC7773825", "33392262"]}, {"Citation": "Okba N.M.A., M\u00fcller M.A., Li W., Wang C., GeurtsvanKessel C.H., Corman V.M., Lamers M.M., Sikkema R.S., de Bruin E., Chandler F.D., et al. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients. Emerg. Infect. Dis. 2020;26:1478\u20131488. doi: 10.3201/eid2607.200841.", "ArticleIdList": ["10.3201/eid2607.200841", "PMC7323511", "32267220"]}, {"Citation": "Cheng M.P., Papenburg J., Desjardins M., Kanjilal S., Quach C., Libman M., Dittrich S., Yansouni C.P. Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review. Ann. Intern. Med. 2020;172:726\u2013734. doi: 10.7326/M20-1301.", "ArticleIdList": ["10.7326/M20-1301", "PMC7170415", "32282894"]}, {"Citation": "Wu C., Qavi A.J., Hachim A., Kavian N., Cole A.R., Moyle A.B., Wagner N.D., Sweeney-Gibbons J., Rohrs H.W., Gross M.L., et al. Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain. iScience. 2021;24:102681. doi: 10.1016/j.isci.2021.102681.", "ArticleIdList": ["10.1016/j.isci.2021.102681", "PMC8168301", "34095780"]}, {"Citation": "Di D., Dileepan M., Ahmed S., Liang Y., Ly H. Recombinant SARS-CoV-2 Nucleocapsid Protein: Expression, Purification, and Its Biochemical Characterization and Utility in Serological Assay Development to Assess Immunological Responses to SARS-CoV-2 Infection. Pathogens. 2021;10:1039. doi: 10.3390/pathogens10081039.", "ArticleIdList": ["10.3390/pathogens10081039", "PMC8402198", "34451501"]}, {"Citation": "Zeng W., Liu G., Ma H., Zhao D., Yang Y., Liu M., Mohammed A., Zhao C., Yang Y., Xie J., et al. Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochem. Biophys. Res. Commun. 2020;527:618\u2013623. doi: 10.1016/j.bbrc.2020.04.136.", "ArticleIdList": ["10.1016/j.bbrc.2020.04.136", "PMC7190499", "32416961"]}, {"Citation": "Djukic T., Mladenovic M., Stanic-Vucinic D., Radosavljevic J., Smiljanic K., Sabljic L., Devic M., Cujic D., Vasovic T., Simovic A., et al. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2. Virology. 2021;557:15\u201322. doi: 10.1016/j.virol.2021.01.004.", "ArticleIdList": ["10.1016/j.virol.2021.01.004", "PMC7871913", "33582454"]}, {"Citation": "Yue L., Cao H., Xie T., Long R., Li H., Yang T., Yan M., Xie Z. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2. J. Med. Virol. 2021;93:1732\u20131738. doi: 10.1002/jmv.26541.", "ArticleIdList": ["10.1002/jmv.26541", "PMC7537214", "32965677"]}, {"Citation": "Khan W.H., Khan N., Mishra A., Gupta S., Bansode V., Mehta D., Bhambure R., Ansari M.A., Das S., Rathore A.S. Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19. Int. J. Biol. Macromol. 2022;200:428\u2013437. doi: 10.1016/j.ijbiomac.2022.01.094.", "ArticleIdList": ["10.1016/j.ijbiomac.2022.01.094", "PMC8762837", "35051498"]}, {"Citation": "Omasits U., Ahrens C.H., M\u00fcller S., Wollscheid B. Protter: Interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics. 2014;30:884\u2013886. doi: 10.1093/bioinformatics/btt607.", "ArticleIdList": ["10.1093/bioinformatics/btt607", "24162465"]}, {"Citation": "IEDB Analysis Resource.  [(accessed on 6 August 2023)].  Available online:  http://tools.iedb.org/bcell/result/"}, {"Citation": "Jespersen M.C., Peters B., Nielsen M., Marcatili P. BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017;45:W24\u2013W29. doi: 10.1093/nar/gkx346.", "ArticleIdList": ["10.1093/nar/gkx346", "PMC5570230", "28472356"]}, {"Citation": "Guruprasad K., Reddy B.V., Pandit M.W. Correlation between stability of a protein and its dipeptide composition: A novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. 1990;4:155\u2013161. doi: 10.1093/protein/4.2.155.", "ArticleIdList": ["10.1093/protein/4.2.155", "2075190"]}, {"Citation": "Expasy Protparam.  [(accessed on 6 August 2023)].  Available online:  https://web.expasy.org/protparam/"}, {"Citation": "He F. Laemmli-SDS-PAGE. Bio-Protocol. 2011;1:e80. doi: 10.21769/BioProtoc.80.", "ArticleIdList": ["10.21769/BioProtoc.80"]}, {"Citation": "He S., Wang J., Chen H., Qian Z., Hu K., Shi B., Wang J. A Competitive Panning Method Reveals an Anti-SARS-CoV2 Nanobody Specific for an RBD-ACE2 Binding Site. Vaccines. 2023;11:371. doi: 10.3390/vaccines11020371.", "ArticleIdList": ["10.3390/vaccines11020371", "PMC9964001", "36851249"]}, {"Citation": "Yang M., He S.H., Chen X.X., Huang Z.X., Zhou Z.L., Zhou Z.C., Chen Q.Y., Chen S.D., Kang S.S. Structural Insight Into the SARS-CoV2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences. Front. Chem. 2021;8:624765. doi: 10.3389/fchem.2020.624765.", "ArticleIdList": ["10.3389/fchem.2020.624765", "PMC7835709", "33511102"]}, {"Citation": "Virginio V.G., Hern\u00e1ndez A., Rott M.B., Monteiro K.M., Zandonai A.F., Nieto A., Zaha A., Ferreira H.B. A set of recombinant antigens from Echinococcus granulosus with potential for use in the immunodiagnosis of human cystic hydatid disease. Clin. Exp. Immunol. 2003;132:309\u2013315. doi: 10.1046/j.1365-2249.2003.02123.x.", "ArticleIdList": ["10.1046/j.1365-2249.2003.02123.x", "PMC1808712", "12699422"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "24"}, {"Year": "2023", "Month": "10", "Day": "9"}, {"Year": "2023", "Month": "10", "Day": "10"}, {"Year": "2023", "Month": "10", "Day": "30", "Hour": "6", "Minute": "46"}, {"Year": "2023", "Month": "10", "Day": "28", "Hour": "11", "Minute": "44"}, {"Year": "2023", "Month": "10", "Day": "28", "Hour": "1", "Minute": "2"}, {"Year": "2023", "Month": "10", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["37892206", "PMC10604654", "10.3390/biom13101524", "biom13101524"]}}], "PubmedBookArticle": []}